Clinical Data, Mayo Foundation for Medical Education and Research deal

The parties cross-licensed patents covering the UGT1A1 gene. The gene is involved in the metabolism of Camptosar irinotecan, a chemotherapeutic marketed by Pfizer Inc. (PFE, New York, N.Y.) to trea...